3,304
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis

ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 2576-2591 | Received 31 Mar 2021, Accepted 22 May 2021, Published online: 07 Jul 2021

References

  • Ryan JJ, Archer SL. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res. 2014;115:176–188.
  • Runo J, Loyd JE. Primary pulmonary hypertension. Lancet. 2003;361:1533–1544.
  • Lau EM, Giannoulatou E, Celermajer DS, et al. Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol. 2017;14:603.
  • D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343–349.
  • Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012;142:448–456.
  • Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–457.
  • Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21:938–945.
  • Alnuaimat H, Patel S, Cope J. Pulmonary arterial hypertension and associated conditions. Disease-a-Month. 2016;62:382–405.
  • Rajkumar R, Konishi K, Richards TJ, et al. Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2010;298:H1235–H48.
  • Mura M, Cecchini MJ, Joseph M, et al. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension. Respirology. 2019;24:1104–1110.
  • Stearman RS, Bui QM, Speyer G, et al. Systems analysis of the human pulmonary arterial hypertension lung transcriptome. Am J Respir Cell Mol Biol. 2019;60:637–649.
  • Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–210.
  • Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 2012;41:D991–D5.
  • Bricambert J, Alves-Guerra M-C, Esteves P, et al. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun. 2018;9:1–18.
  • Ernst M, Dawud RA, Kurtz A, et al. Comparative computational analysis of pluripotency in human and mouse stem cells. Sci Rep. 2015;5:7927.
  • Lin R, Wang Y, Ji K, et al. Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes. Mol Med Rep. 2018;17:4351–4359.
  • Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–127.
  • Abernathy DG, Kim WK, McCoy MJ, et al. MicroRNAs induce a permissive chromatin environment that enables neuronal subtype-specific reprogramming of adult human fibroblasts. Cell Stem Cell. 2017;21:332–48. e9.
  • Liu J, Wan Y, Li S, et al. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis. Cancer Med. 2020;9:3522–3536.
  • Mao D, Zhang Z, Zhao X, et al. Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma. PeerJ. 2020;8:e8383.
  • Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.
  • Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44.
  • Consortium GO. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32:D258–D61.
  • Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
  • Von Mering C, Huynen M, Jaeggi D, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–261.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
  • Serra A, Önlü S, Coretto P, et al. An integrated quantitative structure and mechanism of action-activity relationship model of human serum albumin binding. J Cheminform. 2019;11:38.
  • Ilhan ZE, Łaniewski P, Thomas N, et al. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675–690.
  • Cooper JD, Han SYS, Tomasik J, et al. Multimodel inference for biomarker development: an application to schizophrenia. Transl Psychiatry. 2019;9:83.
  • Paraskevaidi M, Morais CLM, Ashton KM, et al. Detecting Endometrial Cancer by Blood Spectroscopy: a Diagnostic Cross-Sectional Study. Cancers (Basel). 2020;12:1256.
  • Lei C, Yang D, Chen S, et al. Patterns of immune infiltration in stable and raptured abdominal aortic aneurysms: a gene-expression-based retrospective study. Gene. 2020;762:145056.
  • Xiu M-X, Liu Y-M, Chen G-Y, et al. Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis. Dig Dis Sci 2020 1–13 doi:10.1007/s10620-019-05871-5
  • Zhao B, Wan Z, Wang J, et al. Comprehensive analysis reveals a six-gene signature and associated drugs in mimic inguinal hernia model. Hernia. 2020;24:1211–1219.
  • Fisher RA. On the interpretation of χ 2 from contingency tables, and the calculation of P. J R Stat Soc. 1922;85:87–94.
  • Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
  • Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.
  • Farkas D, Thompson AAR, Bhagwani AR, et al. Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension. Am J Respir Crit Care Med. 2019;199:199–210.
  • Waxman A, Restrepo-Jaramillo R, Thenappan T, et al. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. N Engl J Med. 2021;384:325–334.
  • Cai W, Li H, Zhang Y, et al. Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis. PeerJ. 2020;8:e8390.
  • McCormick MM, Rahimi F, Bobryshev YV, et al. S100A8 and S100A9 in human arterial wall: implications for atherogenesis. J Biol Chem. 2005;280:41521–41529.
  • Vogl T, Stratis A, Wixler V, et al. Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 2018;128:1852–1866.
  • Farmer DG, Kennedy S. RAGE, vascular tone and vascular disease. Pharmacol Ther. 2009;124:185–194.
  • Meloche J, Courchesne A, Barrier M, et al. Critical role for the advanced glycation end‐products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc. 2013;2:e005157.
  • Okada K, Arai S, Itoh H, et al. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells’ immune functions. J Leukoc Biol. 2016;100:1093–1104.
  • Fontaine M, Planel S, Peronnet E, et al. S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFNγ. PLoS One. 2014;9:e100909.
  • Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood. 2005;105:2955–2962.
  • Wright SD. CD14 and innate recognition of bacteria. J Immunol. 1995;155:6–8.
  • Wu Z, Zhang Z, Lei Z, et al. CD14: biology and role in the pathogenesis of disease. Cytokine Growth Factor Rev. 2019;48:24–31.
  • Cheng Z, Peng H-L, Zhang R, et al. Bone marrow-derived innate macrophages attenuate oxazolone-induced colitis. Cell Immunol. 2017;311:46–53.
  • Li Y, Liu Y, Peng X, et al. NMDA receptor antagonist attenuates bleomycin-induced acute lung injury. PLoS One. 2015;10:e0125873.
  • Machado RD, Aldred MA, James V, et al. Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat. 2006;27:121–132.
  • Harrison RE, Berger R, Haworth SG, et al. Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood. Circulation. 2005;111:435–441.
  • Austin ED, Ma L, LeDuc C, et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circulation. 2012;5:336–343.
  • Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001;108:1141–1150.
  • Zhao X, Bai X, Li J, et al. Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:10532–10540.
  • Xiao G, Zhuang W, Wang T, et al. Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension. J Cell Mol Med. 2020;24:11409–11421.
  • Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115:165–175.
  • Li C, Liu P, Song R, et al. Immune cells and autoantibodies in pulmonary arterial hypertension. Acta Biochim Biophys Sin (Shanghai). 2017;49:1047–1057.
  • Edwards AL, Gunningham SP, Clare GC, et al. Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension. Respirology. 2013;18:1271–1277.
  • Shlyonsky V, Naeije R, Mies F. Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling. Pulm Circ. 2014;4:471–481.
  • Farha S, Dweik R, Rahaghi F, et al. Imatinib in pulmonary arterial hypertension: c-Kit inhibition. Pulm Circ. 2014;4:452–455.